Matinas BioPharma MTNB
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 0.5 | -0.3 | -1,936 | -2 | ||
| 2025Q4 | 0.59 | 83.68 | -0.26 | -1,600 | -2 | |
| 2025Q3 | 1.89 | 102.94 | -0.38 | -1,577 | -2 | |
| 2025Q2 | 0.89 | 35.02 | -1.03 | -1,837 | -5 | |
| 2025Q1 | 0.52 | 117.51 | -0.33 | -1,946 | -2 | |
| 2024Q4 | 0.51 | 99.48 | -1.68 | -8,469 | -8 | |
| 2024Q3 | 3.54 | 102.5 | -0.83 | -4,382 | -4 | |
| 2024Q2 | 7.92 | 102.12 | -1 | -5,840 | -6 | |
| 2024Q1 | 13.55 | 101.34 | -1.5 | -5,902 | -6 | |
| 2023Q4 | 10.81 | 110.78 | -1.22 | -5,887 | -5 | |
| 2023Q3 | 6.5 | 101.3 | -1.56 | -6,134 | -6 | |
| 2023Q2 | 18 | 101.63 | -1 | -6,159 | -6 | |
| 2023Q1 | 23.5 | 101.32 | -1.5 | -5,586 | -6 | |
| 2022Q4 | 25 | 150.8 | -1 | -5,480 | -4 | |
| 2022Q3 | 31.8 | 100.02 | -1 | -5,462 | -5 | |
| 2022Q2 | 39.5 | 100.05 | -1.5 | -5,926 | -6 | |
| 2022Q1 | 40.22 | 129.17 | -1.5 | -7,722 | -6 | |
| 2021Q4 | 50.5 | 100.22 | -1.5 | -6,714 | -7 | |
| 2021Q3 | 65 | 100.6 | -1.5 | -6,878 | -7 | |
| 2021Q2 | 38.75 | 99.98 | -1 | -4,790 | -5 |